stemedica.comHealthcareFounded: 2005Funding to Date: $82.12MM
Stemedica Cell Technologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions.
For more details on financing and valuation for Stemedica, register or login.
View Enterprise Value for Stemedica.
To read this article and more news on Stemedica, register or login.